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Multidrug resistance was defined as being intermediate or resistant
to at least 3 of these 6 drugs: amikacin, gentamicin, ciprofloxacin,
piperacillin, ceftazidime, and imipenem.
Results: Forty-eight episodes of bloodstream infections were iden-
tified in 30 patients (5 women; mean age 28.5 years). Gram-
negative isolates were Pseudomonas aeruginosa in 12 (25%), En-
terobacter cloacae in 4 (8.3%), Escherichia coli in 2 (4.2%), and
Acinetobacter spp in 2 (4.2%) of the episodes. There were more
primary bloodstream infections in the control group, whereas sec-
ondary bloodstream infections from wound infections were more
common in patients in the multidrug-resistant group. Regarding
prior antibiotic use, aminoglycoside use was significantly higher in
patients in the multidrug-resistant group (p<0.001). See Table 1.
Conclusion: Multidrug-resistant strains of bacteria are being in-
creasingly reported. In these cases, the choice of therapy often
becomes limited. Several factors suggest that the emergence and
spread of multidrug-resistant non-fermenting bacteria is related to
the overuse of antimicrobial agents, although the degree of risk ap-
pears to differ with different agents. A strong association between
use and resistance has been documented for carbapenems. In this
study, previous use of aminoglycosides was found to be statistically
significant for MDR strains.
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Introduction: Colistin was re-introduced into clinical practice dur-
ing the last years for the treatment of nosocomial infections caused
by multidrug-resistant Gram-negative bacteria. The aim of this
study is to evaluate the efficacy and side effects of colistin in the
burn infections caused by pan-resistant Pseudomonas aeruginosa
strains.
Materials and Methods: Medical records of seven burn patients
who received colistin were evaluated retrospectively. Underlying
diseases, site of infection, antibacterial susceptibility pattern of
the causative agent, clinical progress, laboratory findings espe-
cially renal function tests, dose of colistin and side effects of col-
istin were the data collected. Deterioration of renal function was
defined as an increase of more than 50% of the baseline to a value
higher than 1.3mg/dL or as a need for renal replacement therapy.
Results: All seven burn patients had burn wounds infected with
pan-resistant P. aeruginosa and two of these also had bacteremia.
Two burn patients died during colistin treatment; one was due to
other causes except infection (extensive burn), and the other had
febrile disease probably associated with P. aeruginosa. Adult pa-
tients who had normal renal function tests received a dose range
of 1-3 million units q8h. Patients received colistin for 4 to 21 days.
Cultures from the infected sites became sterile in the range of 2
days-13 days. Neurotoxicity, nephrotoxicity, skin rash or gastroin-
testinal disturbances was not observed in any of these patients.
Conclusion: Limited data obtained from seven patients show that
intravenous colistin constitutes a relatively safe and effective ther-
apeutic intervention in cases of severe burn infections caused by
multidrug-resistant Gram-negative bacteria.
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Introduction: Fungal infections particularly bloodstream infections
due to Candida spp. cause high morbidity and mortality in health-
care settings. Burn patients are vulnerable to fungal infections be-
cause they generally receive broad spectrum antibacterial therapy
and total parenteral nutrition.
Objective: The objective of this study is to determine the inci-
dence of fungal infections in burn patients.
Materials and Methods: Medical records of 290 burn patients hos-
pitalized between the years 2003 and 2007 at Baskent University
Burn Unit were evaluated retrospectively. Infections were defined
according to the criteria described in Taneja' s article. Two hun-
dred and ninety burn patients were followed during the five-year
period; the ages of the patients were within the range of 2 months
and 90 years and 88 (30%) were female.
Results: Twenty-five fungal infection episodes caused by Candida
spp. were diagnosed in 20 patients during the five-year period.
Fourteen of these episodes were bloodstream infections, six were
urinary tract infections and five were burn wound infections. Nine
of the fourteen (64%) candidemia episodes were due to Candida
albicans and the remaining five (36%) were due to non-albicans
Candida spp.
Conclusion: Management of fungal infections in burn patients
should deserve more attention because of high mortality rates.
Appropriate antifungal therapy is of great importance. One third
of fungal causes of bloodstream infections in this study are non-
albicans Candida strains. The various antifungal susceptibility pro-
files of non-albicans Candida strains mandates the documentation
of antifungal susceptibility results.
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Background: We have previously shown that 30-40% of surgical
patients with recurrent gastrointestinal perforation/anastomotic
leakage, or acute necrotizing pancreatitis develop intraabdominal
candidiasis (IC) (Lancet 1989, 2:1437). These patients benefit of
fluconazole prophylaxis (Px) (Crit Care Med 1999, 27:1066). A cor-
rected Candida colonization index (CCI) ≥0.4 is a major risk factor
for IC (Ann Surg 1994, 220:751). CSP, a new therapy for IC including
azole-resistant Candida spp., may be used for Px of IC.
Objective: To conduct a non-comparative pilot study on the effi-
cacy and safety of caspofungin (CSP) for Px of IC in high-risk surgi-
cal patients.
Methods: Inclusion criteria: age >18, surgery for recurrent gas-
trointestinal perforations/anastomotic leakage or acute pancreati-
tis. Exclusion criteria: documented IC, fluconazole Px. CSP Px (70
mg, then 50 mg/day) was given until resolution of the surgical con-
dition. Candida colonization was monitored 1x weekly at ≥3 sites
and the CCI calculated. Success was defined by the absence of IC
during CSP Px. Occurrence of CSP-related SAE was recorded.
Results: Nineteen patients were enrolled: 16/3 males/females,
median age 69 (range 40-84). Underlying surgical conditions were:
recurrent gastrointestinal perforation/anastomotic leakage (n),
